A detailed history of Philip James Wealth Mangement, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Philip James Wealth Mangement, LLC holds 6,794 shares of LLY stock, worth $5.43 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
6,794
Previous 448 1416.52%
Holding current value
$5.43 Million
Previous $406 Million 1382.52%
% of portfolio
0.74%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $4.9 Million - $6.09 Million
6,346 Added 1416.52%
6,794 $6.02 Billion
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $159,471 - $199,988
-220 Reduced 32.93%
448 $406 Million
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.15%
668 $520 Million
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $350,301 - $412,959
667 New
667 $389 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Philip James Wealth Mangement, LLC Portfolio

Follow Philip James Wealth Mangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philip James Wealth Mangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Philip James Wealth Mangement, LLC with notifications on news.